The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Open accessAbstract
Ewing sarcoma, a highly aggressive bone and soft-tissue cancer, is considered a prime example of the paradigms of a translocation-positive sarcoma: a genetically rather simple disease with a specific and neomorphic-potential therapeutic target, whose oncogenic role was irrefutably defined decades ago. This is a disease that by definition has micrometastatic disease at diagnosis and a dismal prognosis for patients with macrometastatic or recurrent disease. International collaborations have defined the current standard of care in prospective studies, delivering multiple cycles of systemic therapy combined with local treatment; both are associated with significant morbidity that may result in strong psychological and physical burden for survivors. Nevertheless, the combination of non-directed chemotherapeutics and ever-evolving local modalities nowadays achieve a realistic chance of cure for the majority of patients with Ewing sarcoma. In this review, we focus on the current standard of diagnosis and treatment while attempting to answer some of the most pressing questions in clinical practice. In addition, this review provides scientific answers to clinical phenomena and occasionally defines the resulting translational studies needed to overcome the hurdle of treatment-associated morbidities and, most importantly, non-survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Self-citationCancer immunotherapy: harnessing the immune system to battle cancer
Yang, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83871 · Cited by 1,359
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340
Grier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020890 · Cited by 1,328
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231
Cotterill, S. J., Ahrens, S., Paulussen, M., Jürgens, H. F., Voûte, P. A., Gadner, H., & Craft, A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3108 · Cited by 1,040
Ahmed, N., Brawley, V. S., Hegde, M., Robertson, C., Ghazi, A., Gerken, C., Liu, E., Dakhova, O., Ashoori, A., Corder, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0225 · Cited by 1,004
Imaging dynamic and selective low-complexity domain interactions that control gene transcription
Chong, S., Dugast-Darzacq, C., Liu, Z., Dong, P., Dailey, G. M., Cattoglio, C., Heckert, A., Banala, S., Lavis, L., Darzacq, X., et al. (2018) · Science · doi:10.1126/science.aar2555 · Cited by 966
Genetic and transcriptional evolution alters cancer cell line drug response
Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C. A., Dempster, J., Lyons, N. J., Burns, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0409-3 · Cited by 931
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Self-citationThe Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*
MANKIN, H. J., MANKIN, C. J., & SIMON, M. A. (1996) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199605000-00004 · Cited by 773
Womer, R. B., West, D. C., Krailo, M. D., Dickman, P. S., Pawel, B. R., Grier, H. E., Marcus, K., Sailer, S., Healey, J. H., Dormans, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5703 · Cited by 757
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Gaspar, N., Hawkins, D. S., Dirksen, U., Lewis, I. J., Ferrari, S., Le Deley, M.-C., Kovar, H., Grimer, R., Whelan, J., Claude, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5256 · Cited by 722
Self-citationAmbros, I. M., Ambros, P. F., Strehl, S., Kovar, H., Gadner, H., & Salzer-Kuntschik, M. (1991) · Cancer · doi:10.1002/1097-0142(19910401)67:7<1886::aid-cncr2820670712>3.0.co;2-u · Cited by 657
Self-citationThe hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.
Mankin, H. J., Lange, T. A., & Spanier, S. S. (1982) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198264080-00002 · Cited by 648
Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy310 · Cited by 617
Self-citationEwing, J. (1972) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.22.2.95 · Cited by 583
Esiashvili, N., Goodman, M., & Marcus, R. B. (2008) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31816e22f3 · Cited by 582
Nesbit, M. E., Gehan, E. A., Burgert, E. O., Vietti, T. J., Cangir, A., Tefft, M., Evans, R., Thomas, P., Askin, F. B., & Kissane, J. M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.10.1664 · Cited by 570
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
The Genomic Landscape of Pediatric Ewing Sarcoma
Crompton, B. D., Stewart, C., Taylor-Weiner, A., Alexe, G., Kurek, K. C., Calicchio, M. L., Kiezun, A., Carter, S. L., Shukla, S. A., Mehta, S. S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1037 · Cited by 566
Tirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête-Lalami, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 565
Surviving at a Distance: Organ-Specific Metastasis
Obenauf, A. C., & Massagué, J. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.07.009 · Cited by 565
Stylianopoulos, T., Munn, L. L., & Jain, R. K. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.02.005 · Cited by 563
Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial
Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., van den Berg, H., Dirksen, U., Hjorth, L., Michon, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9864 · Cited by 540
Self-citationBone metastasis: the importance of the neighbourhood
Croucher, P. I., McDonald, M. M., & Martin, T. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.44 · Cited by 479
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
Pierron, G., Tirode, F., Lucchesi, C., Reynaud, S., Ballet, S., Cohen-Gogo, S., Perrin, V., Coindre, J.-M., & Delattre, O. (2012) · Nature Genetics · doi:10.1038/ng.1107 · Cited by 478
Erkizan, H. V., Kong, Y., Merchant, M., Schlottmann, S., Barber-Rotenberg, J. S., Yuan, L., Abaan, O. D., Chou, T.-H., Dakshanamurthy, S., Brown, M. L., et al. (2009) · Nature Medicine · doi:10.1038/nm.1983 · Cited by 452
Self-citationLocalized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86
Paulussen, M., Ahrens, S., Dunst, J., Winkelmann, W., Exner, G. U., Kotz, R., Amann, G., Dockhorn-Dworniczak, B., Harms, D., Müller-Weihrich, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1818 · Cited by 445
Inferring expressed genes by whole-genome sequencing of plasma DNA
Ulz, P., Thallinger, G. G., Auer, M., Graf, R., Kashofer, K., Jahn, S. W., Abete, L., Pristauz, G., Petru, E., Geigl, J. B., et al. (2016) · Nature Genetics · doi:10.1038/ng.3648 · Cited by 441
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
Brohl, A. S., Solomon, D. A., Chang, W., Wang, J., Song, Y., Sindiri, S., Patidar, R., Hurd, L., Chen, L., Shern, J. F., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004475 · Cited by 435
Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts
Hoffman, R. M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3972 · Cited by 425
Antonescu, C. R., Owosho, A. A., Zhang, L., Chen, S., Deniz, K., Huryn, J. M., Kao, Y.-C., Huang, S.-C., Singer, S., Tap, W., et al. (2017) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000846 · Cited by 405
Burgert, E. O., Nesbit, M. E., Garnsey, L. A., Gehan, E. A., Herrmann, J., Vietti, T. J., Cangir, A., Tefft, M., Evans, R., & Thomas, P. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1514 · Cited by 380
Potentiation of X-Ray Effects by Actinomycin D
D’Angio, G. J., Farber, S., & Maddock, C. L. (1959) · Radiology · doi:10.1148/73.2.175 · Cited by 379
Beauchamp, E. M., Ringer, L., Bulut, G., Sajwan, K. P., Hall, M. D., Lee, Y.-C., Peaceman, D., Özdemirli, M., Rodriguez, O., Macdonald, T. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42874 · Cited by 351
Self-citationSchuck, A., Ahrens, S., Paulussen, M., Kuhlen, M., Könemann, S., Rübe, C., Winkelmann, W., Kotz, R., Dunst, J., Willich, N., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03797-5 · Cited by 348
Olmos, D., Postel-Vinay, S., Molife, L. R., Okuno, S. H., Schuetze, S. M., Paccagnella, M. L., Batzel, G. N., Yin, D., Pritchard-Jones, K., Judson, I., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70354-7 · Cited by 340
Hardes, J., von Eiff, C., Streitbuerger, A., Balke, M., Budny, T., Henrichs, M. P., Hauschild, G., & Ahrens, H. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21498 · Cited by 337
Self-citationTranscriptomic definition of molecular subgroups of small round cell sarcomas
Watson, S., Perrin, V., Guillemot, D., Reynaud, S., Coindre, J., Karanian, M., Guinebretière, J., Freneaux, P., Le Loarer, F., Bouvet, M., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5053 · Cited by 335
Granowetter, L., Womer, R., Devidas, M., Krailo, M., Wang, C., Bernstein, M., Marina, N., Leavey, P., Gebhardt, M., Healey, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1478 · Cited by 330
Worst, B. C., van Tilburg, C. M., Balasubramanian, G. P., Fiesel, P., Witt, R., Freitag, A., Boudalil, M., Previti, C., Wolf, S., Schmidt, S., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.06.009 · Cited by 330
Self-citationReduction of MDSCs with all-trans retinoic acid improves CAR therapy efficacy for sarcomas
Long, A. H., Highfill, S. L., Cui, Y., Smith, J. P., Walker, A. J., Ramakrishna, S., El-Etriby, R., Galli, S., Tsokos, M. G., Orentas, R. J., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0230 · Cited by 329
EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma
Gorthi, A., Romero, J. C., Loranc, E., Cao, L., Lawrence, L. A., Goodale, E., Iniguez, A. B., Bernard, X., Masamsetti, V. P., Roston, S., et al. (2018) · Nature · doi:10.1038/nature25748 · Cited by 329
Self-citationItaliano, A., Mir, O., Mathoulin-Pelissier, S., Penel, N., Piperno-Neumann, S., Bompas, E., Chevreau, C., Duffaud, F., Entz-Werlé, N., Saada, E., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30825-3 · Cited by 326
Pappo, A. S., Patel, S. R., Crowley, J., Reinke, D. K., Kuenkele, K.-P., Chawla, S. P., Toner, G. C., Maki, R. G., Meyers, P. A., Chugh, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0000 · Cited by 322
Sarcoma treatment in the era of molecular medicine
Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319
Self-citationMiser, J. S., Kinsella, T. J., Triche, T. J., Tsokos, M., Jarosinski, P., Forquer, R., Wesley, R., & Magrath, I. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1191 · Cited by 317
Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies
Paulussen, M., Ahrens, S., Burdach, S., Craft, A., Dockhorn-Dworniczak, B., Dunst, J., Fröhlich, B., Winkelmann, W., Zoubek, A., & Jürgens, H. (1998) · Annals of Oncology · doi:10.1023/a:1008208511815 · Cited by 317
Risk of recurrence and survival after relapse in patients with Ewing sarcoma
Stahl, M., Ranft, A., Paulussen, M., Bölling, T., Vieth, V., Bielack, S., Görtitz, I., Braun‐Munzinger, G., Hardes, J., Jürgens, H., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23040 · Cited by 315
Self-citationHawkins, D. S., Schuetze, S. M., Butrynski, J. E., Rajendran, J. G., Vernon, C. B., Conrad, E. U., & Eary, J. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7079 · Cited by 286
Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours
Anderson, W. J., & Doyle, L. A. (2021) · Histopathology · doi:10.1111/his.14265 · Cited by 286
Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., & Iwamoto, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119152 · Cited by 277
Kao, Y.-C., Owosho, A. A., Sung, Y.-S., Zhang, L., Fujisawa, Y., Lee, J.-C., Wexler, L., Argani, P., Swanson, D., Dickson, B. C., et al. (2018) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000965 · Cited by 275
Modification of radiation injury to normal tissues by chemotherapeutic agents
Phillips, T. L., Wharam, M. D., & Margolis, L. W. (1975) · Cancer · doi:10.1002/1097-0142(197506)35:6<1678::aid-cncr2820350629>3.0.co;2-k · Cited by 266
Paulussen, M., Craft, A. W., Lewis, I., Hackshaw, A., Douglas, C., Dunst, J., Schuck, A., Winkelmann, W., Köhler, G., Poremba, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5720 · Cited by 263
Promiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 258
Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues
Phillips, T. L., & Fu, K. K. (1976) · Cancer · doi:10.1002/1097-0142(197602)37:2+<1186::aid-cncr2820370830>3.0.co;2-v · Cited by 255
Metastatic bone disease: Pathogenesis and therapeutic options
D'Oronzo, S., Coleman, R., Brown, J., & Silvestris, F. (2019) · Journal of Bone Oncology · doi:10.1016/j.jbo.2018.10.004 · Cited by 255
Assemblages: Functional units formed by cellular phase separation
Toretsky, J. A., & Wright, P. E. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201404124 · Cited by 252
Self-citationBisogno, G., De Salvo, G. L., Bergeron, C., Gallego Melcón, S., Merks, J. H., Kelsey, A., Martelli, H., Minard-Colin, V., Orbach, D., Glosli, H., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30617-5 · Cited by 251
The Insulin-like Growth Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts
Toretsky, J. A., Kalebic, T., Blakesley, V., LeRoith, D., & Helman, L. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30822 · Cited by 250
Self-citationDNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Sheffield, N. C., Pierron, G., Klughammer, J., Datlinger, P., Schönegger, A., Schuster, M., Hadler, J., Surdez, D., Guillemot, D., Lapouble, E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4273 · Cited by 249
Self-citationRodríguez‐Galindo, C., Liu, T., Krasin, M. J., Wu, J., Billups, C. A., Daw, N. C., Spunt, S. L., Rao, B. N., Santana, V. M., & Navid, F. (2007) · Cancer · doi:10.1002/cncr.22821 · Cited by 239
Modeling Ewing sarcoma tumors in vitro with 3D scaffolds
Fong, E. L. S., Lamhamedi-Cherradi, S.-E., Burdett, E., Ramamoorthy, V., Lazar, A. J., Kasper, F. K., Farach-Carson, M. C., Vishwamitra, D., Demicco, E. G., Menegaz, B. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221403110 · Cited by 239
Craft, A. W., Cotterill, S. J., Malcolm, A., Spooner, D. A., Grimer, R. J., Souhami, R. L., Imeson, J., & Lewis, I. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3628 · Cited by 226
Molecular signature associated with bone marrow micrometastasis in human breast cancer.
Wölfle, U., Cloos, J. J., Sauter, G., Riethdorf, L., Jänicke, F., van Diest, P. J., Brakenhoff, R. H., & Pantel, K. (2003) · PubMed · Cited by 225
Panciera, T., Citron, A., Di Biagio, D., Battilana, G., Gandin, A., Giulitti, S., Forcato, M., Bicciato, S., Panzetta, V., Fusco, S., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-0615-x · Cited by 220
Survival After Recurrence of Ewing’s Sarcoma Family of Tumors
Barker, L. M., Pendergrass, T. W., Sanders, J. E., & Hawkins, D. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.105 · Cited by 219
Franzetti, G.-A., Laud-Duval, K., van der Ent, W., Brisac, A., Irondelle, M., Aubert, S., Dirksen, U., Bouvier, C., de Pinieux, G., Snaar-Jagalska, E., et al. (2017) · Oncogene · doi:10.1038/onc.2016.498 · Cited by 219
Self-citationLlombart-Bosch, A., Machado, I., Navarro, S., Bertoni, F., Bacchini, P., Alberghini, M., Karzeladze, A., Savelov, N., Petrov, S., Alvarado-Cabrero, I., et al. (2009) · Virchows Archiv · doi:10.1007/s00428-009-0842-7 · Cited by 217
Tap, W. D., Demetri, G., Barnette, P., Desai, J., Kavan, P., Tozer, R., Benedetto, P. W., Friberg, G., Deng, H., McCaffery, I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2359 · Cited by 217
Viel, A., Bruselles, A., Meccia, E., Fornasarig, M., Quaia, M., Canzonieri, V., Policicchio, E., Urso, E. D., Agostini, M., Genuardi, M., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.022 · Cited by 217
Bond, M., Bernstein, M. L., Pappo, A., Schultz, K. R., Krailo, M., Blaney, S. M., & Adamson, P. C. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21132 · Cited by 211
Juergens, H., Daw, N. C., Geoerger, B., Ferrari, S., Villarroel, M., Aerts, I., Whelan, J., Dirksen, U., Hixon, M. L., Yin, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0670 · Cited by 211
Self-citationScreening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT
Schmidt, G. P., Schoenberg, S. O., Schmid, R., Stahl, R., Tiling, R., Becker, C. R., Reiser, M. F., & Baur-Melnyk, A. (2007) · European Radiology · doi:10.1007/s00330-006-0361-8 · Cited by 209
Naing, A., LoRusso, P., Fu, S., Hong, D. S., Anderson, P., Benjamin, R. S., Ludwig, J., Chen, H. X., Doyle, L. A., & Kurzrock, R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0061 · Cited by 205
A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346
Donaldson, S. S., Torrey, M., Link, M. P., Glicksman, A., Gilula, L., Laurie, F., Manning, J., Neff, J., Reinus, W., Thompson, E., et al. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00191-6 · Cited by 205
Leavey, P. J., Mascarenhas, L., Marina, N., Chen, Z., Krailo, M., Miser, J., Brown, K., Tarbell, N., Bernstein, M. L., Granowetter, L., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21618 · Cited by 204
Szuhai, K., IJszenga, M., de Jong, D., Karseladze, A., Tanke, H. J., & Hogendoorn, P. C. W. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2184 · Cited by 204
3D Scaffolds with Different Stiffness but the Same Microstructure for Bone Tissue Engineering
Chen, G., Dong, C., Yang, L., & Lv, Y. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b02662 · Cited by 204
Miser, J. S., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.041 · Cited by 203
Italiano, A., Di Mauro, I., Rapp, J., Pierron, G., Auger, N., Alberti, L., Chibon, F., Escande, F., Voegeli, A.-C., Ghnassia, J.-P., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00583-5 · Cited by 191
Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience
Casey, D. A., Wexler, L. H., Merchant, M. S., Chou, A. J., Merola, P. R., Price, A. P., & Meyers, P. A. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22206 · Cited by 190
DuBois, S. G., Krailo, M. D., Gebhardt, M. C., Donaldson, S. S., Marcus, K. J., Dormans, J., Shamberger, R. C., Sailer, S., Nicholas, R. W., Healey, J. H., et al. (2015) · Cancer · doi:10.1002/cncr.29065 · Cited by 189
Self-citationRearrangement bursts generate canonical gene fusions in bone and soft tissue tumors
Anderson, N. D., de Borja, R., Young, M. D., Fuligni, F., Rosic, A., Roberts, N. D., Hajjar, S., Layeghifard, M., Novokmet, A., Kowalski, P. E., et al. (2018) · Science · doi:10.1126/science.aam8419 · Cited by 183
Self-citationMeyer, J. S., Nadel, H. R., Marina, N., Womer, R. B., Brown, K. L. B., Eary, J. F., Gorlick, R., Grier, H. E., Randall, R. L., Lawlor, E. R., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21596 · Cited by 180
Targeting the DNA Repair Pathway in Ewing Sarcoma
Stewart, E., Goshorn, R., Bradley, C., Griffiths, L. M., Benavente, C., Twarog, N. R., Miller, G. M., Caufield, W., Freeman, B. B., Bahrami, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.028 · Cited by 180
Kolb, E. A., Kushner, B. H., Gorlick, R., Laverdiere, C., Healey, J. H., LaQuaglia, M. P., Huvos, A. G., Qin, J., Vu, H. T., Wexler, L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.033 · Cited by 180
Le Deley, M.-C., Paulussen, M., Lewis, I., Brennan, B., Ranft, A., Whelan, J., Le Teuff, G., Michon, J., Ladenstein, R., Marec-Bérard, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.4833 · Cited by 179
Self-citationChoy, E., Butrynski, J. E., Harmon, D. C., Morgan, J. A., George, S., Wagner, A. J., D’Adamo, D., Cote, G. M., Flamand, Y., Benes, C. H., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-813 · Cited by 176
Sankar, S., Theisen, E. R., Bearss, J., Mulvihill, T., Hoffman, L. M., Sorna, V., Beckerle, M. C., Sharma, S., & Lessnick, S. L. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0072 · Cited by 173
Evans, R. G., Nesbit, M. E., Gehan, E. A., Garnsey, L. A., Burgert, O., Vietti, T. J., Cangir, A., Tefft, M., Thomas, P., & Askin, F. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1173 · Cited by 171
Aynaud, M.-M., Mirabeau, O., Gruel, N., Grossetête, S., Boeva, V., Durand, S., Surdez, D., Saulnier, O., Zaïdi, S., Gribkova, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.049 · Cited by 171
Self-citationWhelan, J., Le Deley, M.-C., Dirksen, U., Le Teuff, G., Brennan, B., Gaspar, N., Hawkins, D. S., Amler, S., Bauer, S., Bielack, S., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.2516 · Cited by 170
Self-citationTopotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors
Hunold, A., Weddeling, N., Paulussen, M., Ranft, A., Liebscher, C., & Jürgens, H. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20719 · Cited by 168
Scotlandi, K., Remondini, D., Castellani, G., Manara, M. C., Nardi, F., Cantiani, L., Francesconi, M., Mercuri, M., Caccuri, A. M., Serra, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2542 · Cited by 168
Rodriguez‐Galindo, C., Billups, C. A., Kun, L. E., Rao, B. N., Pratt, C. B., Merchant, T. E., Santana, V. M., & Pappo, A. S. (2002) · Cancer · doi:10.1002/cncr.10192 · Cited by 166
Haeusler, J., Ranft, A., Boelling, T., Gosheger, G., Braun‐Munzinger, G., Vieth, V., Burdach, S., van den Berg, H., Juergens, H., & Dirksen, U. (2010) · Cancer · doi:10.1002/cncr.24740 · Cited by 166
Self-citationDirksen, U., Brennan, B. M. D., Deley, M. L., Cozic, N., van den Berg, H., Bhadri, V. A., Brichard, B., Claude, L., Craft, A. W., Amler, S., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00915 · Cited by 166
Self-citationAdvances in immune checkpoint inhibitors for bone sarcoma therapy
Thanindratarn, P., Dean, D. C., Nelson, S. D., Hornicek, F. J., & Duan, Z. (2019) · Journal of Bone Oncology · doi:10.1016/j.jbo.2019.100221 · Cited by 165
Bacci, G., Forni, C., Longhi, A., Ferrari, S., Donati, D., De Paolis, M., Barbieri, E., Pignotti, E., Rosito, P., & Versari, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.022 · Cited by 164
Markers of angiogenesis and clinical features in patients with sarcoma
DuBois, S. G., & Demetri, G. D. (2007) · Cancer · doi:10.1002/cncr.22455 · Cited by 163
Self-citationUndifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Wang, L., Bhargava, R., Zheng, T., Wexler, L., Collins, M. H., Roulston, D., & Ladanyi, M. (2007) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.070053 · Cited by 161
Berghuis, D., Santos, S. J., Baelde, H. J., Taminiau, A. H., Maarten Egeler, R., Schilham, M. W., Hogendoorn, P. C., & Lankester, A. C. (2011) · The Journal of Pathology · doi:10.1002/path.2819 · Cited by 159
Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations
Berger‐Richardson, D., & Swallow, C. J. (2016) · Cancer · doi:10.1002/cncr.30370 · Cited by 159
Patient‐derived xenografts for individualized care in advanced sarcoma
Stebbing, J., Paz, K., Schwartz, G. K., Wexler, L. H., Maki, R. G., Pollock, R. E., Morris, R., Cohen, R., Shankar, A., Blackman, G., et al. (2014) · Cancer · doi:10.1002/cncr.28696 · Cited by 157
Nagarajan, R., Clohisy, D. R., Neglia, J. P., Yasui, Y., Mitby, P. A., Sklar, C. A., Finklestein, J. Z., Greenberg, M., Reaman, G. H., Zeltzer, L. K., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602220 · Cited by 157
Oxidative stress in the lung – The essential paradox
Rogers, L. K., & Cismowski, M. J. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.09.001 · Cited by 156
Jo, V. Y., & Doyle, L. A. (2016) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2016.05.001 · Cited by 155
Shulman, D. S., Klega, K., Imamovic-Tuco, A., Clapp, A., Nag, A., Thorner, A. R., Van Allen, E., Ha, G., Lessnick, S. L., Gorlick, R., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0212-9 · Cited by 149
Self-citationEWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar, H., Aryee, D. N. T., Jug, G., Henöckl, C., SCHEMPER, M., Delattre, O., Thomas, G. D., & Gadner, H. (1996) · PubMed · Cited by 147
Self-citationKlega, K. S., Imamović, A., Ha, G., Clapp, A. N., Meyer, S. C., Ward, A., Clinton, C., Nag, A., Allen, E. M. V., Mullen, E. A., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00285 · Cited by 145
Self-citationChen, S. D., Denız, K., Sung, Y., Zhang, L., Dry, S., & Antonescu, C. R. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22336 · Cited by 141
Sorensen, P. H. B., Liu, X. F., Delattre, O., Rowland, J. M., Biggs, C. A., Thomas, G. D., & Triche, T. J. (1993) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199309000-00002 · Cited by 141
Wagner, L. M., Crews, K. R., Iacono, L. C., Houghton, P. J., Fuller, C. E., McCarville, M. B., Goldsby, R. E., Albritton, K. H., Stewart, C. F., & Santana, V. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0175 · Cited by 139
“Skip” metastases in osteosarcoma
Enneking, W. F., & Kagan, A. (1975) · Cancer · doi:10.1002/cncr.2820360937 · Cited by 139
ACCURACY OF COMPUTED TOMOGRAPHY GUIDED CORE NEEDLE BIOPSY OF MUSCULOSKELETAL TUMOURS
Altuntas, A. O., Slavin, J., Smith, P. J. K., Schlicht, S., Powell, G. J., Ngan, S., Toner, G. C., & Choong, P. (2005) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2005.03332.x · Cited by 138
Bernstein, M. L., Devidas, M., Lafreniere, D., Souid, A.-K., Meyers, P. A., Gebhardt, M. C., Stine, K. C., Nicholas, R. W., Perlman, E. J., Dubowy, R. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.1717 · Cited by 135
West, D. C., Grier, H. E., Swallow, M. M., Demetri, G. D., Granowetter, L., & Sklar, J. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.583 · Cited by 132
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
Kailayangiri, S., Altvater, B., Lesch, S., Balbach, S. T., Göttlich, C., Kühnemundt, J., Mikesch, J., Schelhaas, S., Jamitzky, S., Meltzer, J., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.014 · Cited by 131
Self-citationFerrari, S., Hall, K. S., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., Alvegård, T. A., del Prever, A. B., Tamburini, A., Alberghini, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq573 · Cited by 126
A clinicopathologic study of 20 cases of large-cell (atypical) Ewingʼs sarcoma of bone
Nascimento, A. G., Unni, K. K., Pritchard, D. J., Cooper, K. L., & Dahlin, D. C. (1980) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198002000-00003 · Cited by 123
Smith, M. A., Reynolds, C. P., Kang, M. H., Kolb, E. A., Gorlick, R. G., Carol, H., Lock, R. B., Keir, S. T., Maris, J. M., Billups, C. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2572 · Cited by 122
Inhibition of transcription factors with small organic molecules
Berg, T. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.07.023 · Cited by 122
Proton Therapy in Children: A Systematic Review of Clinical Effectiveness in 15 Pediatric Cancers
Leroy, R., Benahmed, N., Hulstaert, F., Damme, N. V., & Ruysscher, D. D. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.10.025 · Cited by 122
Rutkowski, P. L., Kaminska, J. A., Kowalska, M. M., Ruka, W., & Steffen, J. A. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10305 · Cited by 120
Fox, E., PATEL, S. R., Wathen, J. K., Schuetze, S. M., Chawla, S. P., Harmon, D. C., Reinke, D. K., Chugh, R. K., Benjamin, R. S., & Helman, L. J. (2012) · The Oncologist · doi:10.1634/theoncologist.2010-0265 · Cited by 120
EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma
Ban, J., Bennani-Baïti, I. M., Kauer, M., Schaefer, K., Poremba, C., Jug, G., Schwentner, R., Smrzka, O. W., Muehlbacher, K., Aryee, D. N. T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6145 · Cited by 120
Self-citationMossé, Y. P., Fox, E., Teachey, D. T., Reid, J. M., Safgren, S. L., Carol, H., Lock, R. B., Houghton, P. J., Smith, M. A., Hall, D. C., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2675 · Cited by 119
Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall
Shamberger, R. C., LaQuaglia, M. P., Gebhardt, M. C., Neff, J. R., Tarbell, N. J., Marcus, K. C., Sailer, S. L., Womer, R. B., Miser, J. S., Dickman, P. S., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000089857.45191.52 · Cited by 118
EWS Fli-1 Antisense Nanocapsules Inhibits Ewing Sarcoma-Related Tumor in Mice
Lambert, G., Bertrand, J. R., Fattal, E., Subra, F., Pinto‐Alphandary, H., Malvy, C., Auclair, C., & Couvreur, P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3963 · Cited by 118
Minas, T. Z., Surdez, D., Javaheri, T., Tanaka, M., Howarth, M., Kang, H., Han, J. J., Han, Z., Sax, B., Kream, B. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9388 · Cited by 115
Self-citationClinical outcome of children and adults with localized Ewing sarcoma
Gupta, A. A., Pappo, A. S., Saunders, N. R., Hopyan, S., Ferguson, P. C., Wunder, J. S., O’Sullivan, B., Catton, C., Greenberg, M., & Blackstein, M. E. (2010) · Cancer · doi:10.1002/cncr.25144 · Cited by 113
Proton Radiotherapy for Pediatric Ewing's Sarcoma: Initial Clinical Outcomes
Rombi, B., DeLaney, T. F., MacDonald, S. M., Huang, M., Ebb, D. H., Liebsch, N. J., Raskin, K. A., Yeap, B. Y., Marcus, K. J., Tarbell, N. J., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.03.038 · Cited by 113
Kung, F., Pratt, C. B., Vega, R. A., Jaffe, N., Strother, D. R., Schwenn, M. R., Nitschke, R., Homans, A. C., Holbrook, C. T., Golembe, B., et al. (1993) · Cancer · doi:10.1002/1097-0142(19930301)71:5<1898::aid-cncr2820710529>3.0.co;2-q · Cited by 113
Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma
Shankar, A., Ashley, S. E., Craft, A. W., et al. (2003) · Medical and Pediatric Oncology · doi:10.1002/mpo.10248 · Cited by 113
Foulon, S., Brennan, B. M. D., Gaspar, N., Dirksen, U., Jeys, L. M., Cassoni, A. M., Claude, L., Seddon, B. M., Marec‐Bérard, P., Whelan, J., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.03.075 · Cited by 113
Self-citationThe Role of 18 F-FDG-PET/CT in Pediatric Sarcoma
Harrison, D. J., Parisi, M. T., & Shulkin, B. L. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.12.004 · Cited by 110
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
Huang, X., Park, H., Greene, J., Pao, J., Mulvey, E., Zhou, S. X., Albert, C. M., Moy, F., Sachdev, D., Yee, D., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133152 · Cited by 109
Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma
Santoro, M., Lamhamedi-Cherradi, S.-E., Menegaz, B. A., Ludwig, J. A., & Mikos, A. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506684112 · Cited by 109
Sümegi, J., Nishio, J., Nelson, M., Frayer, R. W., Perry, D. A., & Bridge, J. A. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.201 · Cited by 108
Second malignancies after treatment for Ewing’s sarcoma: a report of the CESS-studies
Dunst, J., Ahrens, S., Paulussen, M., Rübe, C., Winkelmann, W., Zoubek, A., Harms, D., & Jürgens, H. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00228-4 · Cited by 108
Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma
Bridge, J. A., Sümegi, J., Druta, M., Bui, M. M., Henderson‐Jackson, E., Linos, K. D., Baker, M. L., Walko, C. M., Millis, S. Z., & Brohl, A. S. (2019) · Modern Pathology · doi:10.1038/s41379-019-0301-1 · Cited by 108
Hip transposition as a limb salvage procedure following the resection of periacetabular tumors
Gebert, C., Weßling, M., Hoffmann, C., Rödl, R. W., Winkelmann, W., Gosheger, G., & Hardes, J. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21820 · Cited by 107
Self-citationPrognostic profiling of the immune cell microenvironment in Ewing´s Sarcoma Family of Tumors
Stahl, D. J., Gentles, A. J., Thiele, R., & Gütgemann, I. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1674113 · Cited by 106
Luksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., Gandola, L., Eriksson, M., Ruggieri, P., Daolio, P. A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds117 · Cited by 105
Hoffmann, C., Ahrens, S., Dunst, J., Hillmann, A., Winkelmann, W., Craft, A. W., G�bel, U., R�be, C., te, P. A. V., Harms, D., et al. (1999) · Cancer · Cited by 103
Prediction of high risk Ewing's sarcoma by gene expression profiling
Ohali, A., Avigad, S., Zaizov, R., Ophir, R., Horn‐Saban, S., Cohen, I. J., Meller, I., Kollender, Y., Issakov, J., & Yaniv, I. (2004) · Oncogene · doi:10.1038/sj.onc.1208060 · Cited by 103
Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors
Sakimura, R., Tanaka, K., Nakatani, F., Matsunobu, T., Li, X., Hanada, M., Okada, T., Nakamura, T., Matsumoto, Y., & Iwamoto, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.21069 · Cited by 101
Howard, S. C., Davidson, A., Luna‐Fineman, S., et al. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26879 · Cited by 101
Miser, J. S., Goldsby, R. E., Chen, Z., Krailo, M., Tarbell, N. J., Link, M. P., Fryer, C. J., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21233 · Cited by 100
Imaging Pediatric Bone Sarcomas
Kaste, S. C. (2011) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2011.05.006 · Cited by 100
Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma
Krumbholz, M., Hellberg, J., Steif, B., Bäuerle, T., Gillmann, C., Fritscher, T., Agaimy, A., Frey, B., Juengert, J., Wardelmann, E., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3028 · Cited by 100
Self-citationAdvanced-Technology Radiation Therapy in the Management of Bone and Soft Tissue Sarcomas
DeLaney, T. F., Trofimov, A. V., Engelsman, M., & Suit, H. D. (2005) · Cancer Control · doi:10.1177/107327480501200104 · Cited by 99
Volchenboum, S. L., Andrade, J., Huang, L., Barkauskas, D. A., Krailo, M., Womer, R. B., Ranft, A., Potratz, J. C., Dirksen, U., Triche, T. J., et al. (2015) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.9 · Cited by 99
Self-citationSchaefer, K., Eisenacher, M., Braun, Y., Brachwitz, K., Wai, D., Dirksen, U., Lanvers‐Kaminsky, C., Juergens, H., Herrero, D., Stegmaier, S., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.01.020 · Cited by 98
Self-citationInhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides
Toretsky, J. A., Connell, Y., Neckers, L., & BHAT, N. K. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005716926800 · Cited by 97
Self-citationRole of immunotherapy in Ewing sarcoma
Morales, E., Olson, M., Cardenas, F. I., Dahiya, S., Luetkens, T., & Atanackovic, D. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000653 · Cited by 97
Pedersen, E. A., Menon, R., Bailey, K. M., Thomas, D. G., Noord, R. A. V., Tran, J. N., Wang, H., Qü, P., Hoering, A., Fearon, E. R., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3422 · Cited by 96
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Guenther, L. M., Dharia, N. V., Ross, L. S., Conway, A. S., Robichaud, A. L., Catlett, J. L., Wechsler, C. S., Frank, E. S., Goodale, A. B., Church, A. J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0372 · Cited by 96
Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model
Villasante, A., Marturano-Kruik, A., Ambati, S. R., Liu, Z., Godier-Furnémont, A., Parsa, H., Lee, B. W., Moore, M. A. S., & Vunjak‐Novakovic, G. (2016) · Theranostics · doi:10.7150/thno.13944 · Cited by 93
Epigenetik erklärt Vielfalt von Krebs bei Kindern
(2017) · TumorDiagnostik & Therapie · doi:10.1055/s-0043-103387 · Cited by 93
Hypoxia and Bone Metastatic Disease
Johnson, R. W., Sowder, M. E., & Giaccia, A. J. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0378-8 · Cited by 93
Baldauf, M. C., Orth, M. F., Dallmayer, M., Marchetto, A., Gerke, J. S., Rubío, R. A., Kıran, M. M., Musa, J., Knott, M. M. L., Ohmura, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20098 · Cited by 93
Self-citationBrasme, J., Chalumeau, M., Oberlin, O., Valteau‐Couanet, D., & Gaspar, N. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.8058 · Cited by 92
Gambarotti, M., Benini, S., Gamberi, G., Cocchi, S., Palmerini, E., Sbaraglia, M., Donati, D. M., Picci, P., Vanel, D., Ferrari, S. M., et al. (2016) · Histopathology · doi:10.1111/his.12985 · Cited by 92
Detection of tumour cells in peripheral blood and bone marrow from ewing tumour patients by rt‐pcr
Pfleiderer, C., Zoubek, A., Gruber, B., Kronberger, M., Ambros, P. F., Lion, T., Fink, F., Gadner, H., & Kovar, H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640211 · Cited by 91
Self-citationEqual quality of life after limb-sparing or ablative surgery for lower extremity sarcomas
Zahlten‐Hinguranage, A., Bernd, L., Ewerbeck, V., & Sabo, D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602104 · Cited by 90
Leacock, S. W., Basse, A. N., Chandler, G. L., Kirk, A., Rakheja, D., & Amatruda, J. F. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007401 · Cited by 90
Self-citationSchafer, E. S., Rau, R. E., Berg, S. L., Liu, X., Minard, C. G., Bishop, A. J. R., Romero, J. C., Hicks, J. M., Nelson, M. D., Voss, S. D., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.28073 · Cited by 90
Ewing‐like sarcoma: An emerging family of round cell sarcomas
Renzi, S., Anderson, N. D., Light, N. D., & Gupta, A. A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27558 · Cited by 89
Whole Lung Irradiation in Patients with Exclusively Pulmonary Metastases of Ewing Tumors
Bölling, T., Schuck, A., Paulussen, M., et al. (2008) · Strahlentherapie und Onkologie · doi:10.1007/s00066-008-1810-x · Cited by 88
Ewing's Sarcoma Oncoprotein EWS–FLI1: The Perfect Target Without a Therapeutic Agent
Üren, A., & Toretsky, J. A. (2005) · Future Oncology · doi:10.2217/14796694.1.4.521 · Cited by 87
Self-citationNovel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors
Hornick, J. L. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.177 · Cited by 86
The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors
Avigad, S., Cohen, I. J., Zilberstein, J., Liberzon, E., Goshen, Y., Ash, S., Meller, I., Kollender, Y., Issakov, J., Zaizov, R., et al. (2004) · Cancer · doi:10.1002/cncr.20059 · Cited by 84
Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients
Odri, G. A., Dumoucel, S., Picarda, G. G. A., Battaglia, S., Lamoureux, F., Corradini, N., Rousseau, J., Tirode, F., Laud, K., Delattre, O., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4272 · Cited by 84
Treatment of Relapsed/Refractory Pediatric Sarcomas With Gemcitabine and Docetaxel
Mora, J., Cruz, C. O., Parareda, A., & de Torres, C. (2009) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181b2598c · Cited by 83
Nanni, P., Landuzzi, L., Manara, M. C., Righi, A., Nicoletti, G., Cristalli, C., Pasello, M., Parra, A., Carrabotta, M., Ferracin, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48634-y · Cited by 82
Grohar, P. J., Glod, J. W., Peer, C. J., Sissung, T. M., Arnaldez, F. I., Long, L., Figg, W. D., Whitcomb, P. O., Helman, L. J., & Widemann, B. C. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3382-x · Cited by 81
Federico, S. M., Pappo, A. S., Sahr, N. A., Sykes, A. D., Campagne, O., Stewart, C. F., Clay, M. R., Bahrami, A., McCarville, M. B., Kaste, S. C., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.06.014 · Cited by 81
Fernández‐Pineda, I., Hudson, M. M., Pappo, A. S., Bishop, M. W., Klosky, J. L., Brinkman, T. M., Srivastava, D. K., Neel, M. D., Rao, B. N., Davidoff, A. M., et al. (2016) · Journal of Cancer Survivorship · doi:10.1007/s11764-016-0556-1 · Cited by 79
The Evolving Role of Proton Beam Therapy for Sarcomas
Frisch, S., & Timmermann, B. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.04.034 · Cited by 78
Self-citationEWSR1‐PATZ1 gene fusion may define a new glioneuronal tumor entity
Siegfried, A., Rousseau, A., Maurage, C., Péricart, S., Nicaise, Y., Escudié, F., Grand, D., Delrieu, A., Gomez‐Brouchet, A., Guellec, S. L., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12619 · Cited by 78
Mutational signature SBS8 predominantly arises due to late replication errors in cancer
Singh, V. K., Rastogi, A., Hu, X., Wang, Y., & De, S. (2020) · Communications Biology · doi:10.1038/s42003-020-01119-5 · Cited by 78
Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA
Hayashi, M., Chu, D. T. W., Meyer, C. F., Llosa, N. J., McCarty, G., Morris, C. D., Levin, A. S., Wolinsky, J., Albert, C. M., Steppan, D. A., et al. (2016) · Cancer · doi:10.1002/cncr.30144 · Cited by 76
The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review)
Liao, Y., Zhou, C., Zeng, H. M., Zuo, D., Wang, Z., YIN, F., HUA, Y.-Q., & CAI, Z.-D. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1521 · Cited by 75
Miller, I. V., Raposo, G., WELSCH, U. N., da Costa, O. P., Thiel, U., Lebar, M., Maurer, M., Bender, H., von Luettichau, I., Richter, G. H. S., et al. (2013) · Biology of the Cell · doi:10.1111/boc.201200086 · Cited by 74
Self-citationKatschnig, A. M., Kauer, M. O., Schwentner, R., Tomazou, E. M., Mutz, C., Linder, M., Sibilia, M. C., Alonso, J., Aryee, D. N. T., & Kovar, H. (2017) · Oncogene · doi:10.1038/onc.2017.202 · Cited by 74
Self-citationA phase II study of ifosfamide in the treatment of recurrent sarcomas in young people
MAGRATH, I. T., Sandlund, J. T., Raynor, A., Rosenberg, S. A., Arasi, V., & Miser, J. S. (1986) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00647446 · Cited by 73
Characterization and Drug Resistance Patterns of Ewing's Sarcoma Family Tumor Cell Lines
May, W. A., Grigoryan, R. S., Keshelava, N., Cabral, D. J., Christensen, L. L., Jenabi, J. M., Ji, L., Triche, T. J., Lawlor, E. R., & Reynolds, C. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080060 · Cited by 72
Zöllner, S. K., Selvanathan, S. P., Graham, G. T., Commins, R., Hong, S. H., Moseley, E., Parks, S. E., Haladyna, J. N., Erkizan, H. V., Dirksen, U., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aam8429 · Cited by 72
Self-citationKoelsche, C., Kriegsmann, M., Kommoss, F. K. F., Stichel, D., Kriegsmann, K., Vokuhl, C., Grünewald, T. G. P., Romero‐Pérez, L., Kirchner, T., de Álava, E., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02895-2 · Cited by 72
Self-citationKnott, M. M. L., Hölting, T. L. B., Ohmura, S., Kirchner, T., Cidre‐Aranaz, F., & Grünewald, T. G. P. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09839-9 · Cited by 72
Self-citationChaturvedi, A. P., Hoffman, L. M., Jensen, C. C., Lin, Y.-C., Grossmann, A. H., Randall, R. L., Lessnick, S. L., Welm, A. L., & Beckerle, M. C. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-01-0007 · Cited by 71
Ban, J., Aryee, D. N. T., Fourtouna, A., van der Ent, W., Kauer, M., Niedan, S., Machado, I., Galindo, C. R., Tirado, Ò. M., Schwentner, R., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1736 · Cited by 69
Self-citationEngert, F., Schneider, C., Weiβ, L. M., Probst, M., & Fulda, S. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0587 · Cited by 69
Cited by
Current insights into the role of Fli-1 in hematopoiesis and malignant transformation
Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04160-1 · Cited by 54
Metadata
- Authors
- Zöllner, S. K., Amatruda, J. F., Bauer, S., Collaud, S., de Álava, E., DuBois, S. G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., Shulman, D. S., Streitbürger, A., Timmermann, B., Toretsky, J. A., Uhlenbruch, Y., Vieth, V., Grünewald, T. G. P., & Dirksen, U.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-04-14
- Volume
- 10
- Issue
- 8
- Pages
- 1685
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W3152750978
- Cited by
- 271
- References
- 294
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.